Abiramy Jeyagaran
Overview
Explore the profile of Abiramy Jeyagaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeyagaran A, Urbanczyk M, Carvajal-Berrio D, Baldissera T, Kaiser P, Kuhlburger L, et al.
Adv Healthc Mater
. 2024 Nov;
14(2):e2403017.
PMID: 39511898
Transplantation of donor islets of Langerhans is a potential therapeutic approach for patients with diabetes mellitus; however, its success is limited by islet death and dysfunction during the initial hypoxic...
2.
Urbanczyk M, Abuhelou A, Koninger M, Jeyagaran A, Carvajal-Berrio D, Kim E, et al.
Tissue Eng Part A
. 2024 Oct;
PMID: 39453887
Endothelial cells (ECs) play a crucial role in maintaining tissue homeostasis and functionality. Depending on their tissue of origin, ECs can be highly heterogeneous regarding their morphology, gene and protein...
3.
Jeyagaran A, Urbanczyk M, Layland S, Weise F, Schenke-Layland K
Sci Rep
. 2024 Jun;
14(1):13608.
PMID: 38871849
Transplantation of stem cell-derived β-cells is a promising therapeutic advancement in the treatment of type 1 diabetes mellitus. A current limitation of this approach is the long differentiation timeline that...
4.
Urbanczyk M, Jeyagaran A, Zbinden A, Lu C, Marzi J, Kuhlburger L, et al.
Matrix Biol
. 2023 Jan;
115:160-183.
PMID: 36592738
Transplantation of islets of Langerhans is a promising alternative treatment strategy in severe cases of type 1 diabetes mellitus; however, the success rate is limited by the survival rate of...
5.
Jeyagaran A, Lu C, Zbinden A, Birkenfeld A, Brucker S, Layland S
Adv Drug Deliv Rev
. 2022 Aug;
189:114481.
PMID: 36002043
The development of new therapeutic approaches to treat type 1 diabetes mellitus (T1D) relies on the precise understanding and deciphering of insulin-secreting β-cell biology, as well as the mechanisms responsible...
6.
Zbinden A, Carvajal Berrio D, Urbanczyk M, Layland S, Bosch M, Fliri S, et al.
J Biophotonics
. 2020 Oct;
13(12):e202000375.
PMID: 33026180
Pancreatic islet isolation from donor pancreases is an essential step for the transplantation of insulin-secreting β-cells as a therapy to treat type 1 diabetes mellitus. This process however damages islet...